CI

At a glance

ClinicalIndex Comparison Record
Phase 3Completed· 120 enrolled
Drug / intervention
Stannous Fluoride +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03072719
NCT03072719Phase 3Completed
CompareCT.gov

A Clinical Study Investigating the Efficacy of a Dentifrice in Providing Immediate and Short Term Relief From Dentinal Hypersensitivity

GlaxoSmithKline·interventional·Posted Mar 7, 2017·Updated Mar 6, 2018

In Brief

A Phase 3 clinical trial evaluating Stannous Fluoride and Sodium Monofluorophosphate for Dentine Hypersensitivity. Completed, enrolled 120 participants across 1 site.

Detailed Summary

A randomised, examiner blind, two treatment arm, stratified, parallel design, single-site study in subjects with at least two sensitive teeth to compare the efficacy of a test dentifrice against that of a control dentifrice in reducing dentinal hypersensitivity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsDentine Hypersensitivity
CountriesIreland
Collaborators--

Timeline

Phase 3CompletedFinished
201220132014201520162017201820192020202120222023202420252026
First PostedMar 7, 2017
Enrollment StartMar 1, 2012
Primary CompletionJun 1, 2012
Study CompletionJun 12, 2012
TodayJul 2, 2026
Enrollment to primary: 3 monthsPosted 9.3 years ago

Interventions

Stannous Fluoridedrug

Test dentifrice, participants will brush each of the 2 selected sensitive teeth each for 30 seconds followed by the whole mouth thoroughly for at least one minute.

Sodium Monofluorophosphatedrug

Control dentifrice, participants will brush the whole mouth thoroughly for at least 1 minute.